LDS Hospital is a general urban hospital and surgical center in Salt Lake City, Utah. The hospital was originally owned by The Church of Jesus Christ of Latter-day Saints, but is now owned and operated by Intermountain Healthcare. LDS Hospital is accredited by the Joint Commission. The hospital has 262 inpatient beds.

During the past decade, LDS Hospital conducted 98 clinical trials. In the 10-year time frame, 98 clinical trials started and 119 clinical trials were completed, i.e. on average, 121.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 44 clinical trials were completed. i.e. 176% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LDS Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 75 trials, followed by "National Cancer Institute (NCI)" with 65 trials sponsored, "SWOG Cancer Research Network" with 49 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored and "Intermountain Health Care, Inc." with 26 trials sponsored. Other sponsors include 113 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LDS Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 200 trials as a collaborator, "NRG Oncology" with 42 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 16 trials as a collaborator, "Radiation Therapy Oncology Group" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 12 trials as a collaborator. Other collaborators include 186 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "LDS Hospital" are "Breast Cancer" (27 trials), "Lung Cancer" (23 trials), "Prostate Cancer" (20 trials), "Head and Neck Cancer" (18 trials) and "Brain and Central Nervous System Tumors" (11 trials). Many other conditions were trialed in "LDS Hospital" in a lesser frequency.

Most popular intervention types in "LDS Hospital" are "Drug" (243 trials), "Radiation" (128 trials), "Other" (125 trials), "Procedure" (97 trials) and "Biological" (90 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (57 trials), "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (40 trials), "cisplatin" (26 trials) and "Paclitaxel" (21 trials). Other intervention names were less common.

The vast majority of trials in "LDS Hospital" are 273 trials for "All" genders, 60 trials for "Female" genders and 23 trials for "Male" genders.

Currently, there are NaN active trials in "LDS Hospital". undefined are not yet recruiting, 24 are recruiting, 76 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 213 completed trials in LDS Hospital, 4 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in LDS Hospital, 20 "Phase 1" clinical trials were conducted, 128 "Phase 2" clinical trials and 177 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 25 trials that are defined as “Not Applicable".